Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.470
+0.090 (3.78%)
At close: Jun 27, 2025, 4:00 PM
2.350
-0.120 (-4.86%)
After-hours: Jun 27, 2025, 4:45 PM EDT
MRVI Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for MRVI stock ranges from a low of $2.00 to a high of $13. The average analyst price target of $6.84 forecasts a 176.92% increase in the stock price over the next year.
Price Target: $6.84 (+176.92%)
Analyst Consensus: Hold
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for MRVI stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 1 | 2 | 2 | 2 | 2 |
Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Hold | 4 | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 11 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +304.86% | May 13, 2025 |
Baird | Baird | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -19.03% | May 13, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +102.43% | Mar 25, 2025 |
UBS | UBS | Hold Maintains $8 → $2.5 | Hold | Maintains | $8 → $2.5 | +1.21% | Mar 21, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +223.89% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
198.76M
from 259.19M
Decreased by -23.31%
Revenue Next Year
219.86M
from 198.76M
Increased by 10.62%
EPS This Year
-0.29
from -1.05
EPS Next Year
-0.23
from -0.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 215.3M | 245.7M | 304.9M | ||
Avg | 198.8M | 219.9M | 248.9M | ||
Low | 181.9M | 199.4M | 223.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -17.0% | 23.6% | 38.7% | ||
Avg | -23.3% | 10.6% | 13.2% | ||
Low | -29.8% | 0.3% | 1.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.19 | -0.07 | -0.06 | ||
Avg | -0.29 | -0.23 | -0.17 | ||
Low | -0.44 | -0.45 | -0.28 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.